Intec Pharma Reports Top-Line Phase 3 Trial Results of Accordion Pill-Carbidopa/Levodopa in Advanced Parkinson's Disease Patients

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Intec Pharma Reports Top-Line Phase 3 Trial Results of Accordion Pill-Carbidopa/Levodopa in Advanced Parkinson's Disease Patients

Maxim Group Downgrades Intec Pharma Ltd. (NTEC) to Hold

July 22, 2019 11:13 AM EDT

Maxim Group analyst Jason McCarthy downgraded Intec Pharma Ltd. (NASDAQ: NTEC) from Buy to Hold.

For an analyst ratings summary and ratings history on Intec Pharma Ltd. click here. For more ratings news on Intec Pharma Ltd. click here.

Shares of Intec Pharma Ltd. closed at $2.99 yesterday.

... More

Intec Pharma (NTEC) to Resume Trading at 7:30 am ET

July 22, 2019 7:25 AM EDT

Intec Pharma (NASDAQ: NTEC) to Resume Trading at 7:30 am ET

... More